Global Healthcare Shift in Therapeutic Botulinum Toxin Type A Market
The global therapeutic botulinum toxin type A market was valued at USD 5.2 billion in 2025 and is projected to reach USD 11.0 billion by 2033, expanding at a CAGR of 10.2% from 2026 to 2033. Market growth is primarily driven by the rising prevalence of neurological and chronic conditions such as migraine, spasticity, dystonia, and movement disorders, along with increasing preference...
0 Kommentare 0 Anteile 5 Ansichten 0 Vorschau